Mr. Speaker, documents obtained under the Access to Information Act show senior bureaucrats at the Department of Industry felt the current Minister of Industry's purchase of Cipro would be a blow for R and D and innovation in Canada. To quote:
The decision by Health Canada to circumvent Canada's Patent Act run[s] counter to this Government's agenda of innovation, economic growth and fostering of a knowledge-based economy.
Why should we believe the minister is suddenly interested in innovation when he has both broken the Patent Act and ignored advice that his actions would have a negative affect on innovation?